STAAR SURGICAL CO (STAA)
US8523123052 - Common Stock
We assign a fundamental rating of 6 out of 10 to STAA. STAA was compared to 193 industry peers in the Health Care Equipment & Supplies industry. While STAA has a great profitability rating, there are some minor concerns on its financial health. STAA shows excellent growth, but is valued quite expensive already. With these ratings, STAA could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
STAA had positive earnings in the past year.
In the past year STAA had a positive cash flow from operations.
In the past 5 years STAA has always been profitable.
STAA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.37%, STAA is in the better half of the industry, outperforming 79.69% of the companies in the same industry.
STAA has a better Return On Equity (5.53%) than 77.60% of its industry peers.
With a decent Return On Invested Capital value of 4.92%, STAA is doing good in the industry, outperforming 77.60% of the companies in the same industry.
STAA had an Average Return On Invested Capital over the past 3 years of 7.40%. This is in line with the industry average of 8.49%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.37% | ||
| ROE | 5.53% | ||
| ROIC | 4.92% |
ROA(3y)6.93%
ROA(5y)5.97%
ROE(3y)8.89%
ROE(5y)7.69%
ROIC(3y)7.4%
ROIC(5y)5.91%
1.3 Margins
STAA has a Profit Margin of 6.62%. This is in the better half of the industry: STAA outperforms 78.65% of its industry peers.
STAA's Profit Margin has improved in the last couple of years.
The Operating Margin of STAA (8.72%) is better than 77.08% of its industry peers.
STAA's Operating Margin has improved in the last couple of years.
STAA has a Gross Margin of 78.36%. This is amongst the best in the industry. STAA outperforms 90.10% of its industry peers.
STAA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.72% | ||
| PM (TTM) | 6.62% | ||
| GM | 78.36% |
OM growth 3Y27.96%
OM growth 5Y10.36%
PM growth 3Y22.42%
PM growth 5Y10.43%
GM growth 3Y2.67%
GM growth 5Y1.21%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), STAA is destroying value.
Compared to 1 year ago, STAA has more shares outstanding
Compared to 5 years ago, STAA has more shares outstanding
STAA has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 13.22 indicates that STAA is not in any danger for bankruptcy at the moment.
STAA's Altman-Z score of 13.22 is amongst the best of the industry. STAA outperforms 90.63% of its industry peers.
STAA has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
STAA has a Debt to Equity ratio of 0.00. This is in the better half of the industry: STAA outperforms 68.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 13.22 |
ROIC/WACC0.51
WACC9.72%
2.3 Liquidity
A Current Ratio of 5.62 indicates that STAA has no problem at all paying its short term obligations.
The Current ratio of STAA (5.62) is better than 73.96% of its industry peers.
STAA has a Quick Ratio of 5.08. This indicates that STAA is financially healthy and has no problem in meeting its short term obligations.
STAA's Quick ratio of 5.08 is fine compared to the rest of the industry. STAA outperforms 77.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.62 | ||
| Quick Ratio | 5.08 |
3. Growth
3.1 Past
The earnings per share for STAA have decreased strongly by -23.08% in the last year.
The Earnings Per Share has been growing by 43.10% on average over the past years. This is a very strong growth
Looking at the last year, STAA shows a quite strong growth in Revenue. The Revenue has grown by 13.37% in the last year.
The Revenue has been growing by 21.06% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-23.08%
EPS 3Y71%
EPS 5Y43.1%
EPS growth Q2Q8.33%
Revenue 1Y (TTM)13.37%
Revenue growth 3Y25.4%
Revenue growth 5Y21.06%
Revenue growth Q2Q19.1%
3.2 Future
Based on estimates for the next years, STAA will show a very strong growth in Earnings Per Share. The EPS will grow by 26.03% on average per year.
The Revenue is expected to grow by 15.03% on average over the next years. This is quite good.
EPS Next Y-2.72%
EPS Next 2Y27.15%
EPS Next 3Y32.45%
EPS Next 5Y26.03%
Revenue Next Year4.83%
Revenue Next 2Y10.51%
Revenue Next 3Y13.62%
Revenue Next 5Y15.03%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
STAA is valuated quite expensively with a Price/Earnings ratio of 71.43.
Based on the Price/Earnings ratio, STAA is valued a bit cheaper than 69.79% of the companies in the same industry.
STAA is valuated expensively when we compare the Price/Earnings ratio to 28.05, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 73.43, the valuation of STAA can be described as expensive.
Based on the Price/Forward Earnings ratio, STAA is valued a bit cheaper than 70.31% of the companies in the same industry.
STAA is valuated expensively when we compare the Price/Forward Earnings ratio to 20.30, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 71.43 | ||
| Fwd PE | 73.43 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of STAA indicates a somewhat cheap valuation: STAA is cheaper than 69.27% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 52.88 |
4.3 Compensation for Growth
STAA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as STAA's earnings are expected to grow with 32.45% in the coming years.
PEG (NY)N/A
PEG (5Y)1.66
EPS Next 2Y27.15%
EPS Next 3Y32.45%
5. Dividend
5.1 Amount
No dividends for STAA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
STAAR SURGICAL CO
NASDAQ:STAA (5/9/2024, 3:03:19 PM)
After market: 42.86 0 (0%)42.86
+1.84 (+4.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.11B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 71.43 | ||
| Fwd PE | 73.43 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)1.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.37% | ||
| ROE | 5.53% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 8.72% | ||
| PM (TTM) | 6.62% | ||
| GM | 78.36% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 5.62 | ||
| Quick Ratio | 5.08 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-23.08%
EPS 3Y71%
EPS 5Y
EPS growth Q2Q
EPS Next Y-2.72%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)13.37%
Revenue growth 3Y25.4%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y